|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
3.610 +0.020 (+0.557%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 9.827% | 10.575% | 9.937% | 8.085% | 13.093% |
| ROAE (%) | 14.023% | 15.181% | 15.061% | 13.008% | 21.893% |
| Return on Capital Employed (%) | 11.678% | 13.510% | 13.648% | 10.477% | 15.915% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 89.198% | 89.750% | 89.928% | 90.257% | 85.229% |
| EBITDA Margin (%) | 26.752% | 25.687% | 23.397% | 23.150% | 26.061% |
| Pre-tax Profit Margin (%) | 22.861% | 22.488% | 19.921% | 19.757% | 24.087% |
| Net Profit Margin (%) | 17.537% | 18.399% | 15.847% | 17.106% | 21.126% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 2.113 X | 1.810 X | 1.536 X | 2.164 X | 2.244 X |
| Quick Ratio (X) | 2.009 X | 1.727 X | 1.458 X | 2.015 X | 2.102 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 30.872% | 28.807% | 31.963% | 36.168% | 39.434% |
| Total Debt / Total Assets (%) | 9.938% | 6.270% | 10.398% | 18.055% | 19.738% |
| Net Debt / Total Assets (%) | -12.485% | -12.408% | -7.633% | -1.982% | -3.707% |
| Total Debt / Shareholders' Funds (%) | 14.376% | 8.807% | 15.284% | 28.286% | 32.589% |
| Long Term Debt / Shareholders' Funds (%) | 11.512% | 5.367% | 2.935% | 22.070% | 23.599% |
| Net Debt / Shareholders' Funds (%) | -18.061% | -17.428% | -11.219% | -3.105% | -6.121% |
| Net Cash / (Debt) ($) | 435.826M | 370.128M | 215.823M | 53.752M | 106.150M |
| Net Cash / (Debt) per share ($) | 0.769 | 0.653 | 0.380 | 0.094 | 0.184 |
| Total Debt / Capital Employed (%) | 12.736% | 8.225% | 14.579% | 22.763% | 25.999% |
| Interest Coverage Ratio (X) | -- | 62.686 X | 31.861 X | 23.693 X | 43.762 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 128.860 Day | 129.832 Day | 152.808 Day | 257.630 Day | 184.550 Day |
| Receivables Turnover (Day) | 118.488 Day | 118.951 Day | 107.017 Day | 152.787 Day | 124.291 Day |
| Payables Turnover (Day) | 1.904 Day | 1.961 Day | 2.231 Day | 2.094 Day | 5.411 Day |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 318,091 |
| %Change | 3.538% |
| EPS / (LPS) | HKD 0.561 |
| NBV Per Share ($) | HKD 4.256 |